Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Response Genetics (RGDXQ)
OTHER OTC:RGDXQ
Holding RGDXQ?
Track your performance easily
RGDXQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.01
Previous Close$0.01
Volume1.50K
Average Volume (3M)N/A
Market Cap
$39.00
Enterprise Value-$13.09M
Total Cash (Recent Filing)$19.46M
Total Debt (Recent Filing)$6.37M
Price to Earnings (P/E)―
Beta-16.80
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation17.25
R-Squared0.00084
Alpha2.91
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.30
Enterprise Value/Gross Profit-3.32
Enterprise Value/Ebitda0.73
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
15.47% Other Institutional Investors
84.53% Public Companies and
Individual Investors
RGDXQ FAQ
What was Response Genetics’s price range in the past 12 months?
Response Genetics lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Response Genetics’s market cap?
Currently, no data Available
When is Response Genetics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Response Genetics’s earnings last quarter?
Currently, no data Available
Is Response Genetics overvalued?
According to Wall Street analysts Response Genetics’s price is currently Overvalued.
Does Response Genetics pay dividends?
Response Genetics does not currently pay dividends.
What is Response Genetics’s EPS estimate?
Response Genetics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Response Genetics have?
Response Genetics has 38,795,000 shares outstanding.
What happened to Response Genetics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Response Genetics?
Currently, no hedge funds are holding shares in RGDXQ
---
Company Description
Response Genetics
Response Genetics, Inc. is engaged in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.
---
Technical Analysis
---